Joana Rita Castro Costa

Title: Joana Rita Castro Costa: Innovator in Pharmaceutical Research

Introduction

Joana Rita Castro Costa is a prominent inventor based in Craigavon, GB. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. Her work focuses on addressing critical health issues such as muscular atrophy, obesity, and type II diabetes.

Latest Patents

Joana holds a patent for "4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)." This patent includes inhibitors of ubiquitin specific protease 19 (USP19) of Formula (I), along with pharmaceutical compositions that comprise these inhibitors. The compounds developed can be utilized in the treatment of muscular atrophy, obesity, insulin resistance, or type II diabetes, and they play a crucial role in reducing the loss of muscle mass.

Career Highlights

Joana is currently employed at Almac Discovery Limited, where she continues to advance her research and development efforts. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Joana collaborates with talented professionals, including Adam Piotr Treder and James Samuel Shane Rountree, who contribute to her research initiatives and help drive innovation within the company.

Conclusion

Joana Rita Castro Costa exemplifies the spirit of innovation in pharmaceutical research, with her groundbreaking patent and collaborative efforts paving the way for advancements in medical treatments.